| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
1 Department of Human Nutritional Sciences, University of Manitoba, Winnipeg, Manitoba, Canada
2 Department of Human Nutritional Sciences, University of Manitoba, Winnipeg, Manitoba, Canada; Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, Manitoba, Canada
* To whom correspondence should be addressed. E-mail: aukema{at}umanitoba.ca.
Renal prostanoids are important regulators of normal renal function and maintenance of renal homeostasis. In diseased kidneys renal cylooxygenase (COX) expression and prostanoid formation are altered. Using the Han:Sprague-Dawley-cy rat, the aim of this study was to determine the relative contribution of renal COX isoforms (protein, gene expression and activity) on renal prostanoid production [thromboxane B2 (TXB2, stable metabolite of TXA2), prostaglandin E2 (PGE2) and 6-keto-prostaglandin F1a (6-keto- PGF1a, stable metabolite of PGI2)] in normal and diseased kidneys. In diseased kidneys, COX-1 immunoreactive protein and mRNA levels were higher and COX-2 levels were lower when compared to normal kidneys. In contrast, COX activities were higher in diseased compared to normal kidneys for both COX-1 [0.05[[plusmn]0.02 vs. 0.45±0.11 ng prostanoids/min/mg protein (P<0.001)] and COX-2 [0.64±0.10 vs. 2.32±0.22 ng prostanoids/min/mg protein (P<0.001)]. As the relative difference in activity was greater for COX-1, the ratio of COX-1/COX-2 was higher in diseased compared to normal kidneys, although the predominant activity was still due to the COX-2 isoform in both genotypes. Endogenous and steady-state in vitro levels of prostanoids were ~2-10 times higher in diseased compared to normal kidneys. The differences between normal and diseased kidney prostanoids was in the order of TXB2 > 6-keto-PGF1a > PGE2, as determined by higher renal prostanoid levels and COX activity ratios of TXB2/6-keto- PGF1a, TXB2/PGE2 and 6-keto-PGF1a /PGE2 . This specificity in both the COX isoform type and for the prostanoids produced has implications for normal and diseased kidneys in treatments involving selective inhibition of COX isoforms.
This article has been cited by other articles:
|
|
 |
|
  C. Y.-C. Peng, D. Sankaran, M. R. Ogborn, and H. M. Aukema Dietary Soy Protein Selectively Reduces Renal Prostanoids and Cyclooxygenases in Polycystic Kidney Disease Experimental Biology and Medicine, July 1, 2009; 234(7): 737 - 743. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Drury, L. J. Warford-Woolgar, D. J. Herchak, N. Bankovic-Calic, G. Crow, C. G. Taylor, P. Zahradka, M. R. Ogborn, and H. M. Aukema Dietary trans-10, cis-12 Conjugated Linoleic Acid Reduces Early Glomerular Enlargement and Elevated Renal Cyclooxygenase-2 Levels in Young Obese fa/fa Zucker Rats J. Nutr., February 1, 2009; 139(2): 285 - 290. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Sankaran, N. Bankovic-Calic, M. R. Ogborn, G. Crow, and H. M. Aukema Selective COX-2 inhibition markedly slows disease progression and attenuates altered prostanoid production in Han:SPRD-cy rats with inherited kidney disease Am J Physiol Renal Physiol, September 1, 2007; 293(3): F821 - F830. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
